In conclusion, similar to hs-cTnT, cMyC at admission may be a potent, independent predictor of 6-month all-cause mortality in patients without ACS treated at medical CICUs, and their prognostic abilities may be comparable. Combining cMyC or hs-cTnT with NT-proBNP may substantially improve early risk stratification of this population.
Prognostic value of combining cMyC and NT-proBNT in patients without ACS treated at medical cardiac ICU’s
- Hideto Nishimura, Junnichi Ishii, Hiroshi Takahashi, Yuya Ishihara, Kazuhiro Nakamura, Fumihiko Kitagawa, Eirin Sakaguchi, Yuko Sasaki, Hideki Kawai, Takashi Muramatsu, Masahide Harada, Akira Yamada, Sadako Tanizawa-Motoyama, Hiroyuki Naruse, Masayoshi Sarai, Masanobu Yanase, Hideki Ishii, Eiichi Watanabe, Yukio Ozaki & Hideo Izawa
- Springer Nature
